Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Passage Bio, Inc. (PASG) had Operating Cash Flow per Share of $-15.88 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-64.77M |
|
-- |
|
-- |
|
$70.40M |
|
$-70.40M |
|
$5.63M |
|
$-64.77M |
|
$-64.77M |
|
$-64.77M |
|
$-64.77M |
|
$-64.77M |
|
$-64.77M |
|
$-70.40M |
|
$-68.85M |
|
3.02M |
|
3.02M |
|
$-21.40 |
|
$-21.40 |
|
| Balance Sheet Financials | |
$78.81M |
|
$9.33M |
|
$23.60M |
|
$102.41M |
|
$19.36M |
|
-- |
|
$21.79M |
|
$41.15M |
|
$61.26M |
|
$61.26M |
|
$61.26M |
|
3.10M |
|
| Cash Flow Statement Financials | |
$-47.96M |
|
$54.95M |
|
$8.87M |
|
$21.71M |
|
$37.57M |
|
$15.86M |
|
$5.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-105.72% |
|
-105.72% |
|
-63.24% |
|
-105.72% |
|
$19.74 |
|
$-15.89 |
|
|
Operating Cash Flow per Share |
$-15.88 |